A Study Of SHR-1918 In Participants With Hypercholesterolemia With Inadequate Lipid Control on Statins Plus PCSK9 Inhibitors
A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 126 participants.
Also called NCT07404553
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 2/3
- Enrolled
- 126 participants
- Registry
-
NCT07404553
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Recruiting
Technical summary
Registry record NCT07404553. Randomized; quadruple masking; primary purpose treatment. Start 2026-04-30 (actual); primary completion 2028-07 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Study Of SHR-1918 In Participants With Hypercholesterolemia With Inadequate Lipid Control on Statins Plus PCSK9 Inhibitors
- Condition
- Hypercholesterolemia
- Intervention (Drug)
- SHR-1918 Injection
- Intervention (Drug)
- SHR-1918 Injection Placebo
- Lead sponsor
- Beijing Suncadia Pharmaceuticals Co., Ltd
Record details
- Record id
cardio:ct-nct07404553- Content hash
de0b0e1428cf34fa42ca42384e5da7c8694976561634ab9c513d0f6740df8317